Previous 10 | Next 10 |
-- Consortium Developed an Integrated Solution for Better Preparedness and Faster Response to Outbreaks and Epidemics in High-Risk Areas -- The Praesens Foundation, the Institut Pasteur, the Institut Pasteur de Dakar, University of Nebraska Medical Center and Twist Bioscience Corporati...
-- Reports Exceptional Data from Sample Preparation with FFPE and Saliva Samples to Streamline NGS Workflows -- -- Adds Mitochondrial Custom Panel -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthet...
Introduction to the Positive/Negative Forensic Value Stock Selections This quantitative study continues a series of multi-year test of the top three forensic algorithms used to detect bankruptcy risk, earnings manipulation, and financial irregularities. My forward testing compiles portfolio ...
-- Previews Disruptive Gene Pools Product that Includes up to 180,000 Genes for Drug Discovery, Protein Screening and More, at $0.04 per Base Pair – -- Silicon-based DNA Synthesis Platform Continues to Enable Innovative Products Across Synthetic Biology, Next-Generation Sequenc...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced several presentations at SynBioBeta 2019, the leading industry conference bringing together biological engineers,...
Any analyst worth their salt will warn investors that nothing changes quickly in healthcare. Of course, the old axiom doesn't apply to the prices investors will pay for promising new healthcare stocks. These three healthcare stocks made their first appearance on the Nasdaq exchan...
The following slide deck was published by Twist Bioscience Corporation in conjunction with this Read more ...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Jim Thorburn, CFO of Twist Bioscience, ...
I have a confession: I don't like the market environment that we are in. I would much prefer to invest at a time when government bonds have 5% real yields, when the Shiller P/E ratio is at 10, and when businesses reinvest their profits instead of buying back stock, while borrowing to the hilt....
Twist Bioscience Corporation (TWST) Q3 2019 Results Earnings Conference Call August 01, 2019, 04:30 PM ET Company Participants Jim Thorburn - Chief Financial Officer Emily Leproust - CEO and Cofounder of Twist Conference Call Participants Doug Schenkel - Cowen Catherine Sch...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...